Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMOX1 | P09601 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14272742 | 1.00 | HMOX1 (0.33) | HMOX1 | |
| SCHEMBL12022240 | 0.87 | HMOX1 (0.33) | HMOX1 | |
| SCHEMBL16310950 | 0.83 | HMOX1 (0.32) | HMOX1 | |
| SCHEMBL10309206 | 0.81 | HMOX1 (0.34) | HMOX1 | |
| SCHEMBL7086407 | 0.78 | KDM4E (0.36) | HMOX1 | |
| SCHEMBL13180165 | 0.78 | HMOX1 (0.33) | HMOX1 | |
| SCHEMBL10618639 | 0.77 | GRIN1 (0.31) | — | |
| SCHEMBL16310949 | 0.76 | KDM4E (0.34) | — | |
| SCHEMBL13283453 | 0.75 | CHRM2 (0.33) | — | |
| SCHEMBL5945117 | 0.75 | HMOX1 (0.31) | HMOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118266623-A | Apple-flavored essence and electronic cigarette tobacco tar and preparation method thereof | 比亚迪精密制造有限公司 | 2024-07-02 | — | — | CN | disclosed |
| WO-2020216034-A1 | INTERMEDIATE OF ERIBULIN, SYNTHESIS METHOD THEREFOR AND USE THEREOF | 北京天一绿甫医药科技有限公司 | 2020-10-29 | — | — | WO | disclosed |
| CN-108424818-A | Cleaning masks liquid composition | 东友精细化工有限公司 | 2018-08-21 | — | — | CN | disclosed |
| US-9028600-B2 | Inkjet ink, inkjet recording method, and inkjet recording device | RICOH COMPANY, LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-01 | — | — | US | disclosed |
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-1307441-A1 | 1,3-DIOXOLANES WITH ANTITUSSIVE ACTIVITY | Dompe' S.P.A. (IT) | 2003-05-07 | — | — | EP | disclosed |
| WO-2002010149-A1 | 1,3-DIOXOLANES WITH ANTITUSSIVE ACTIVITY | DOMPE' S.P.A. (IT) | 2002-02-07 | — | — | WO | disclosed |
| EP-0254078-B1 | PYRAN DERIVATIVES | BASF Aktiengesellschaft (DE) | 1991-02-06 | — | — | EP | disclosed |
| EP-0254078-A1 | Pyran derivatives | BASF Aktiengesellschaft (DE) | 1988-01-27 | — | — | EP | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | NR2C2, NR4A3, NR0B2 | HMOX1 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.